Results 1 to 10 of about 306,685 (235)

Integrated analysis of the gut microbiome and metabolome in a mouse model of inflammation-induced colorectal tumors

open access: yesFrontiers in Microbiology, 2023
Colorectal cancer (CRC) is a common malignancy worldwide, and the gut microbiota and metabolites play an important role in its initiation and progression.
Yuntian Hong   +15 more
doaj   +1 more source

Causal association between constipation and risk of colorectal cancer: a bidirectional two-sample Mendelian randomization study

open access: yesFrontiers in Oncology, 2023
BackgroundColorectal cancer (CRC) is a globally significant health concern, necessitating effective preventive strategies through identifying modifiable risk factors. Constipation, characterized by infrequent bowel movements or difficulty passing stools,
Long Wu   +6 more
doaj   +1 more source

The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases [PDF]

open access: yesGut Microbes, 2022
The intestinal microbiota is recognized to play a role in the defense against infection, but conversely also acts as a reservoir for potentially pathogenic organisms. Disruption to the microbiome can increase the risk of invasive infection from these organisms; therefore, strategies to restore the composition of the gut microbiota are a potential ...
Rohma Ghani   +4 more
openaire   +5 more sources

Case report: A rare case of pyruvate kinase deficiency and Crigler-Najjar syndrome type II with a novel pathogenic variant of PKLR and UGT1A1 mutation

open access: yesFrontiers in Genetics, 2023
Pyruvate Kinase Deficiency (PKD) and Crigler-Najjar syndrome are rare autosomal recessive liver diseases. PKD is caused by homozygous or compound heterozygous mutations in the PKLR gene, leading to non-spherocytic hereditary hemolytic anemia.
Huan Wu   +3 more
doaj   +1 more source

Interrupted time series analysis using the ARIMA model of the impact of COVID-19 on the incidence rate of notifiable communicable diseases in China

open access: yesBMC Infectious Diseases, 2023
Background The coronavirus disease 2019 (COVID-19) pandemic in China is ongoing. Some studies have shown that the incidence of respiratory and intestinal infectious diseases in 2020 decreased significantly compared with previous years.
Qin Zhou   +4 more
doaj   +1 more source

Epidemiological characteristics of the notifiable infectious diseases reported in Shanghai in 2020

open access: yesShanghai yufang yixue, 2023
ObjectiveTo understand the epidemic characteristics of notifiable infectious diseases (NIDs) other than coronavirus disease 2019 (COVID-19) in Shanghai in 2020, and to provide evidence for formulating infectious disease prevention and control strategies ...
FU Meihua   +3 more
doaj   +1 more source

Intimal macrophages develop from circulating monocytes during vasculitis

open access: yesClinical & Translational Immunology, 2022
Objective Vasculitis is characterised by inflammation of the blood vessels. While all layers of the vessel can be affected, inflammation within the intimal layer can trigger thrombosis and arterial occlusion and is therefore of particular clinical ...
Angus T Stock   +7 more
doaj   +1 more source

Notifiable infectious diseases among children aged 0 to 6 years old in Hudong Community of Shanghai from 2011 to 2018

open access: yesShanghai yufang yixue, 2022
ObjectiveTo understand the incidence characteristics and epidemic tendency of notifiable infectious diseases (NID) among children aged 0 to 6 years old in Hudong Community of Shanghai from 2011 to 2018, in order to provide a scientific basis for the ...
FANG Xinli, ZHENG Yingjie
doaj   +1 more source

Home - About - Disclaimer - Privacy